| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA462837
Max Phase: Preclinical
Molecular Formula: C22H23NO4
Molecular Weight: 365.43
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(CN3CCCC3)cc1)O2
Standard InChI: InChI=1S/C22H23NO4/c1-25-19-12-17-18(13-20(19)26-2)27-21(22(17)24)11-15-5-7-16(8-6-15)14-23-9-3-4-10-23/h5-8,11-13H,3-4,9-10,14H2,1-2H3/b21-11-
Standard InChI Key: QSSBCGZXNNGKPI-NHDPSOOVSA-N
Associated Targets(non-human)
Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) 232 Activities
Butyrylcholinesterase 745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acetylcholinesterase 2577 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 365.43 | Molecular Weight (Monoisotopic): 365.1627 | AlogP: 3.92 | #Rotatable Bonds: 5 |
| Polar Surface Area: 48.00 | Molecular Species: BASE | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.56 | CX LogP: 3.23 | CX LogD: 2.05 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.75 | Np Likeness Score: -0.44 |
References
| 1. Sheng R, Xu Y, Hu C, Zhang J, Lin X, Li J, Yang B, He Q, Hu Y.. (2009) Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives., 44 (1): [PMID:18436348] [10.1016/j.ejmech.2008.03.003] |
Source
Source(1):